This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Need quick cash? Check out these ways to earn money on the same day and start generating income in no time.
19,298 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A major investment manager disclosed a sizable share disposal in a U.S. utility stock through an SEC filing. The move...
When Nvidia shares stumble, savvy investors look for high-potential AI names that can keep delivering. Here are two s...
Markets move to risk-off mode as geopolitical threats push U.S. stock futures sink. Traders weigh energy prices, infl...
Tether, the issuer of the USDT stablecoin, has hired a Big Four firm to perform its first comprehensive audit, aiming...
Across wealth brackets, meme coins are more than a joke. This guide explains why some millionaire investors dabble in...
The Nasdaq has slipped into correction territory, raising questions about the next move. This guide uncovers historic...
A veteran portfolio manager recounts selling a 19-bagger too early and explains how that misstep reshaped his long-te...
When mortgage markets swung on interest-rate headlines, one fund pressed deeper into PennyMac. This article explains ...
A new voter poll shows broad demand for federal action to reduce housing costs, with cross‑party support for quick pa...
Oklo stock climbing higher this week is driven by regulatory progress on its Aurora reactor and broader interest in a...
Tron’s TRX surged in 2026, yet fresh on-chain data points to a potential correction risk as price outpaces network ac...